Advertisement

Complications of Transobturator Synthetic Slings

  • Melissa R. Kaufman
  • Laura Chang-Kit
  • Elizabeth T. Brown
  • Roger R. Dmochowski
Chapter

Abstract

Transobturator (TOT) placement of midurethral slings has demonstrated excellent efficacy similar to retropubic approaches with regard to treatment of female SUI; however, the TOT vector of implantation has also manifested a select and unique complication profiles. In addition to recognized complications of all midurethral slings, including mesh erosion, postoperative voiding dysfunction, and obstruction, intricacies of TOT placement and obturator foramen anatomy dictate individualized evaluation and management of complications. Indeed, de novo neurologic manifestations of thigh and groin pain mandate TOT-specific treatment strategies. Management of TOT complications are discussed in this book as the vaginal mesh kits use the same transobturator approach used for TOT slings and may require a some of the same approaches for removal.

Keywords

Transobturator sling Female stress incontinence Mesh complications 

References

  1. 1.
    Reynolds WS, Dmochowski RR, Penson DF. Epidemiology of stress urinary incontinence in women. Curr Urol Rep. 2011;12(5):370–6.CrossRefGoogle Scholar
  2. 2.
    Lemack G, Anger J. Urinary incontinence and pelvic prolapse: epidemiology and pathophysiology. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology, vol. 3. 11th ed. Philadelphia: Elsevier; 2016. p. 1743–60.Google Scholar
  3. 3.
    van Geelen J, Hunskaar S. The epidemiology of female urinary incontinence. Eur Clin Obstet Gynecol. 2005;1:3.CrossRefGoogle Scholar
  4. 4.
    Koski ME, Chamberlain J, Rosoff J, Vaughan T, Kaufman MR, Winters JC, et al. Patient perception of transvaginal mesh and the media. Urology. 2014;84(3):575–82.CrossRefGoogle Scholar
  5. 5.
    Wood LN, Anger JT. Urinary incontinence in women. BMJ. 2014;349:g4531.CrossRefGoogle Scholar
  6. 6.
    Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11:1306–13.PubMedGoogle Scholar
  7. 7.
    U.S. Food & Drug Administration. Medical devices. Urogynecologic surgical mesh implants. FDA’s role and activities. Updated 4 Jan 2016. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm262301.htm. Accessed 15 Sept 2017.
  8. 8.
    U.S. Food & Drug Administration. Medical devices. Considerations about surgical mesh for SUI. Updated 27 Mar 2013. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm. Accessed 15 Sept 2017.
  9. 9.
    American Urogynecologic Society (AUGS) and the Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU). Position Statement. Mesh midurethral slings for stress urinary incontinence. Jan 2014; updated Jun 2016. http://sufuorg.com/docs/news/augs-sufu-mus-position-statement.aspx. Accessed 15 Sept 2017.
  10. 10.
    Dmochowski RR, Osborn DJ, Reynolds WS. Slings: autologous, biologic, synthetic, and midurethral. In: Wein AJ, Kavoussi LR, Partin AW, Peters CA, editors. Campbell-Walsh urology. 11th, vol. 3. Philadelphia: Elsevier; 2016. p. 1987–2038.Google Scholar
  11. 11.
    Tash J, Staskin DR. Artificial graft slings at the midurethra: physiology of continence. Curr Urol Rep. 2003;4(5):367–70.CrossRefGoogle Scholar
  12. 12.
    Fritel X, Zabak K, Pigne A, Demaria F, Benifla JL. Predictive value of urethral mobility before suburethral tape procedure for urinary stress incontinence in women. J Urol. 2002;168(6):2472–5.CrossRefGoogle Scholar
  13. 13.
    Petri E, Niemeyer R, Martan A, Tunn R, Naumann G, Koelbl H. Reasons for and treatment of surgical complications with alloplastic slings. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(1):3–13.CrossRefGoogle Scholar
  14. 14.
    Dmochowski RR, Blaivas JM, Gormley EA, Juma S, Karram MM, Lightner DJ, et al. Female Stress Urinary Incontinence Update Panel of the American Urological Association Education and Research, Inc, Whetter LE. Update of AUA guideline on the surgical management of female stress urinary incontinence J Urol. 2010;183(5):1906–14.CrossRefGoogle Scholar
  15. 15.
    Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010;362(22):2066–76.CrossRefGoogle Scholar
  16. 16.
    Haylen BT, Freeman RM, Swift SE, Cosson M, Davila GW, Deprest J, et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) & grafts in female pelvic floor surgery. Int Urogynecol J. 2011;22(1):3–15.CrossRefGoogle Scholar
  17. 17.
    Karram M, Pancholy A. Synthetic midurethral slings for the correction of stress urinary incontinence. In: Baggish MS, Karram MM, editors. Atlas of pelvic anatomy and gynecologic surgery. 3rd ed. St. Louis: Elsevier Saunders; 2011. p. 747–80.Google Scholar
  18. 18.
    Corton MM. Critical anatomic concepts for safe surgical mesh. Clin Obstet Gynecol. 2013;56(2):247–56.CrossRefGoogle Scholar
  19. 19.
    Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009 Oct 07(4):CD006375.Google Scholar
  20. 20.
    Ko JK, Ku CH. Embolization for pelvic arterial bleeding following a transobturator tape procedure. J Obstet Gynecol Res. 2013;40(3):865–8.CrossRefGoogle Scholar
  21. 21.
    Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008;180(5):1890–7.CrossRefGoogle Scholar
  22. 22.
    Shah SR, Nitti VW. Diagnosis and treatment of obstruction following incontinence surgery—urethrolysis and other techniques. In: Cardoza L, Staskin D, editors. Textbook of female urology and urogynecology. 3rd ed. London: Informa UK Ltd; 2010. p. 749–62.CrossRefGoogle Scholar
  23. 23.
    Nitti VW, Raz S. Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis. J Urol. 1994;152(1):93–8.CrossRefGoogle Scholar
  24. 24.
    Gomelsky A, Nitti VW, Dmochowski RR. Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology. 2003;62(3):391–9. ReviewCrossRefGoogle Scholar
  25. 25.
    Carr LK, Webster GD. Voiding dysfunction following incontinence surgery: diagnosis and treatment with retropubic or vaginal urethrolysis. J Urol. 1997;157(3):821–3.CrossRefGoogle Scholar
  26. 26.
    FitzGerald MP, Brubaker L. The etiology of urinary retention after surgery for genuine stress incontinence. Neurourol Urodyn. 2001;20(1):13–21.CrossRefGoogle Scholar
  27. 27.
    Mishra VC, Mishra N, Karim OM, Motiwala HG. Voiding dysfunction after tension-free vaginal tape: a conservative approach is often successful. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(3):210–4; discussion: 4.CrossRefGoogle Scholar
  28. 28.
    Dmochowski RR, Karram MM, Reynolds WS. Surgery for urinary incontinence: female pelvic surgery video atlas series. Expert consult: online and print, Female pelvic video surgery atlas series. Philadelphia: Elsevier Saunders; 2013.Google Scholar
  29. 29.
    Staack A, Vitale J, Ragavendra N, Rodriguez LV. Translabial ultrasonography for evaluation of synthetic mesh in the vagina. Urology. 2014;83(1):68–74.CrossRefGoogle Scholar
  30. 30.
    Chang-Kit L, Kaufman MR, Dmochowski RR. Complications of biologic and synthetic slings and their management. In: Goldman HB, editor. Complications of female incontinence and pelvic reconstructive surgery, Current clinical urology. New York: Springer Science+Business Media; 2013. p. 115–32.CrossRefGoogle Scholar
  31. 31.
    Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–63.CrossRefGoogle Scholar
  32. 32.
    Amundsen CL, Flynn BJ, Webster GD. Urethral erosion after synthetic and nonsynthetic pubovaginal slings: differences in management and continence outcome. J Urol. 2003;170(1):134–7. discussion 7CrossRefGoogle Scholar
  33. 33.
    Oh TH, Ryu DS. Transurethral resection of intravesical mesh after midurethral sling procedures. J Endourol. 2009;23(8):1333–7.CrossRefGoogle Scholar
  34. 34.
    Doumouchtsis SK, Lee FY, Bramwell D, Fynes MM. Evaluation of holmium laser for managing mesh/suture complications of continence surgery. BJU Int. 2011;108(9):1472–8.CrossRefGoogle Scholar
  35. 35.
    Yamada BS, Govier FE, Stefanovic KB, Kobashi KC. High rate of vaginal erosions associated with the mentor ObTape. J Urol 2006;176(2):651–4; discussion: 4.CrossRefGoogle Scholar
  36. 36.
    Roth TM. Serratia marcescens thigh infection after transobturator sling without associated mesh exposure. Female Pelvic Med Reconstr Surg. 2015;21(2):e19–20.CrossRefGoogle Scholar
  37. 37.
    Kim TH, Lee HH, Kim JM. Chronic vaginal discharge and left leg edema after a transobturator tape procedure. Int Urogynecol J. 2014;25(5):695–7.CrossRefGoogle Scholar
  38. 38.
    Choi H, Bae JH, Lee JG. Severe thigh abscess two years after transobturator sling operation. Low Urin Tract Symptoms. 2011;3(1):51–4.CrossRefGoogle Scholar
  39. 39.
    Rardin CR, Moore R, Ward RM, Myers DL. Recurrent thigh abscess with necrotizing fasciitis from a retained transobturator sling segment. J Minim Invasive Gynecol. 2009;16(1):84–7.CrossRefGoogle Scholar
  40. 40.
    Goldman HB. Large thigh abscess after placement of synthetic transobturator sling. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(3):295–6.CrossRefGoogle Scholar
  41. 41.
    Danford JM, Osborn DJ, Reynolds WS, Biller DH, Dmochowski RR. Postoperative pain outcomes after transvaginal mesh revision. Int Urogynecol J. 2015;26(1):65–9.CrossRefGoogle Scholar
  42. 42.
    Hou JC, Alhalabi F, Lemack GE, Zimmern PE. Outcome of transvaginal mesh and tape removed for pain only. J Urol. 2014;192(3):856–60.CrossRefGoogle Scholar
  43. 43.
    Laurikainen E, Valpas A, Kivela A, Kalliola T, Rinne K, Takala T, et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2007;109(1):4–11.CrossRefGoogle Scholar
  44. 44.
    Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol. 2011;205(5):498.e1–6.CrossRefGoogle Scholar
  45. 45.
    Chinthakanan O, Miklos JR, Moore RD, Karp DR, Nogueiras GM, Davila GW. The indication and surgical treatment of 286 midurethral synthetic sling complications: a multicenter study. Surg Technol Int. 2016;29:167–71.PubMedGoogle Scholar
  46. 46.
    Reynolds WS, Kit LC, Kaufman MR, Karram M, Bales GT, Dmochowski RR. Obturator foramen dissection for excision of symptomatic transobturator mesh. J Urol. 2012;187(5):1680–4.CrossRefGoogle Scholar
  47. 47.
    King AB, Tenggardjaja C, Goldman HB. Prospective evaluation of the effect of thigh dissection for removal of transobturator mid urethral slings on refractory thigh pain. J Urol. 2016;196(4):1207–12.CrossRefGoogle Scholar
  48. 48.
    Petri E, Ashok K. Comparison of late complications of retropubic and transobturator slings in stress urinary incontinence. Int Urogynecol J. 2012;23(3):321–5.CrossRefGoogle Scholar
  49. 49.
    Zyczynski HM, Rickey L, Dyer KY, Wilson T, Stoddard AM, Gormley EA, et al. Sexual activity and function in women more than 2 years after midurethral sling placement. Am J Obstet Gynecol. 2012;207(5):421.e1–6.CrossRefGoogle Scholar
  50. 50.
    Moss CF, Damitz LA, Gracely RH, Mintz AC, Zolnoun DA, Dellon AL. Dorsal clitoral nerve injury following transobturator midurethral sling. J Pain Res. 2016;9:727–30.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Melissa R. Kaufman
    • 1
  • Laura Chang-Kit
    • 2
  • Elizabeth T. Brown
    • 3
  • Roger R. Dmochowski
    • 1
  1. 1.Department of Urology, Vanderbilt Medical CenterNashvilleUSA
  2. 2.Department of Urology, Albany Medical CenterAlbanyUSA
  3. 3.Department of Urology, MedStar Georgetown University HospitalWashington, DCUSA

Personalised recommendations